UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Learn various ways to generate fast income through smart investing. Take control of your financial future now.
25,734 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Target just gave investors a fresh reason to rethink risk and opportunity in retail. After a solid earnings beat and ...
A sweeping proposal from former President Donald Trump and ex-Fed official Kevin Warsh would dramatically increase So...
A bid for the 2027 budget would cut a job-training program for low-income seniors, potentially eliminating support fo...
Enbridge approaches its 52-week high as cash flow strengthens and a robust project backlog fuels optimism. Analysts c...
When one tech giant climbs and another stumbles, the market often stays coldsweat steady. Learn how Micron’s strength...
As Brazil begins a measured rate-cut cycle, EWZ may emerge as a tactical edge in 2026. A slower Fed and a stronger BR...
Geopolitical tensions flare as reports detail a more aggressive Iran posture. Bitcoin and other risk assets react as ...
The average long-term U.S. mortgage rate eased to its lowest in more than three years, yet remains above 6%, keeping ...
Lowe’s beat on near-term earnings but issued a muted FY26 outlook, sending its stock lower while TJX jumped on strong...
A fiery address from Palantir’s CEO has ignited a broader debate on how AI firms partner with the Pentagon and how po...
Taxpayers face longer waits for refunds as agencies update forms for new rules and software. New York and Idaho highl...